| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |